Log in Free sign up

Novo Integrated Sciences (NVOS) News and press releases

News

From Benzinga Pro

Novo Integrated Sciences Q2 EPS $(0.17) Down From $(0.06) YoY, Sales $2.87M Up From $2.08M YoY

Novo Integrated Sciences (NASDAQ:NVOS) reported quarterly losses of $(0.17) per share. This is a 183.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $2.87

Novo Integrated Sciences Signs Memorandum Of Understanding With Boditech Med To Market And Distribute In North America; Terms Not Disclosed

News, Contracts

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services

63 Biggest Movers From Yesterday

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.

Novo Integrated Sciences' PRO-DIP Issued U.S. Patent For Oral Pouch Delivery System Technology

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem with

Press releases

From Benzinga Pro

Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results

Management expects Triple-digit Percentage Revenue Growth sequentially for the Fiscal 2022 Third Quarter Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to

Novo Integrated Sciences' PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem with multiple patient and

Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product

Novo Integrated Sciences' IoNovo Iodide Granted Natural Product Number (NPN) by Health Canada

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product